![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
C Schultz, M Vajanaphanich, HG Genieser, B Jastorff, KE Barrett and RY Tsien
Department of Pharmacology, University of California, San Diego, La Jolla 92093.
A novel membrane-permeant derivative of cAMP, cAMP acetoxymethyl ester (cAMP/AM), was synthesized via silylated intermediates. Its ability to induce Cl- secretion by T84 cells, a human colon cancer cell line, was compared with that of two other membrane-permeant cAMP derivatives that were recently introduced, N6,O2'-dibutyryl-cAMP acetoxymethyl ester (bt2cAMP/AM) and Sp-5,6-dichlorobenzimidazole-1-beta-D-ribofuranoside 3',5'-cyclic phosphorothioate (Sp-5,6-DCl-cBIMPS). All of these compounds are powerful activators of Cl- secretion when applied extracellularly, with EC50 values of 60 microM, 0.7 microM, and 3 microM, respectively. However, cAMP/AM was expected to be readily degraded inside cells, in contrast to the cyclophosphodiesterase- resistant Sp-5,6-DCI-cBIMPS or the only slowly metabolizable N6-butyryl- cAMP derived from bt2cAMP/AM. Reversibility of cAMP/AM action was demonstrated by wash-out experiments; Cl- secretion induced by high doses of cAMP/AM (100 microM) could be quickly abolished by rinsing of the cells, whereas similar experiments with bt2cAMP/AM and Sp-5,6-DCI- cBIMPS showed much slower decreases. Even more sensitive to residual cAMP derivatives was the synergistic effect of carbachol, which was applied after the incubation with membrane-permeant derivatives and their subsequent wash-out. Although doses of cAMP derivatives that barely activated Cl- secretion were readily capable of inducing a synergistic response with carbachol, cells incubated with high doses of cAMP/AM (100 microM) and subsequently washed showed only a nonsynergistic carbachol response, in contrast to cells incubated with bt2cAMP/AM or Sp-5,6-DCI-cBIMPS. We therefore characterize cAMP/AM as a membrane-permeant derivative of cAMP that is easily metabolizable inside cells and hence is most useful for applications where a transient intracellular cAMP signal is desired. In contrast, completely nonmetabolizable Sp-5,6-DCI-cBIMPS seems to be more useful in longer incubations that require steady levels of cAMP-dependent protein kinase activation. bt2cAMP/AM combines the advantages of intracellular trapping by ester hydrolysis and reduced cyclophosphodiesterase sensitivity of its active intracellular product, which probably lead to its particularly high potency.
This article has been cited by other articles:
|
|
 |
|
  C. Grunberger, B. Obermayer, J. Klar, A. Kurtz, and F. Schweda The Calcium Paradoxon of Renin Release: Calcium Suppresses Renin Exocytosis by Inhibition of Calcium-Dependent Adenylate Cyclases AC5 and AC6 Circ. Res., November 24, 2006; 99(11): 1197 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Bertelsen, K. E. Barrett, and S. J. Keely Gs Protein-coupled Receptor Agonists Induce Transactivation of the Epidermal Growth Factor Receptor in T84 Cells: IMPLICATIONS FOR EPITHELIAL SECRETORY RESPONSES J. Biol. Chem., February 20, 2004; 279(8): 6271 - 6279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Carlson, R. E. Westenbroek, T. Quill, D. Ren, D. E. Clapham, B. Hille, D. L. Garbers, and D. F. Babcock CatSper1 required for evoked Ca2+ entry and control of flagellar function in sperm PNAS, December 9, 2003; 100(25): 14864 - 14868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Wennemuth, A. E. Carlson, A. J. Harper, and D. F. Babcock Bicarbonate actions on flagellar and Ca2+-channel responses: initial events in sperm activation Development, April 1, 2003; 130(7): 1317 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kopperud, A. E. Christensen, E. Kjarland, K. Viste, H. Kleivdal, and S. O. Doskeland Formation of Inactive cAMP-saturated Holoenzyme of cAMP-dependent Protein Kinase under Physiological Conditions J. Biol. Chem., April 12, 2002; 277(16): 13443 - 13448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, Y. Ma, S. S. Taylor, and R. Y. Tsien Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering PNAS, December 18, 2001; 98(26): 14997 - 15002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Freeze Update and perspectives on congenital disorders of glycosylation Glycobiology, December 1, 2001; 11(12): 129R - 143R. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Fox and P. E. Lloyd Role of cAMP in the Short-Term Modulation of a Neuromuscular System in Aplysia J Neurophysiol, March 1, 2000; 83(3): 1567 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jiang, G. Sweeney, M. T. Rudolf, A. Klip, A. Traynor-Kaplan, and R. Y. Tsien Membrane-permeant Esters of Phosphatidylinositol 3,4,5-Trisphosphate J. Biol. Chem., May 1, 1998; 273(18): 11017 - 11024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shah, Y. Liu, C. Deirmengian, and K. M. Shokat Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates PNAS, April 15, 1997; 94(8): 3565 - 3570. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
